The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer’s disease

This publication has 45 references indexed in Scilit:

• Cell Therapy for Stroke
  Stroke, 2009
• β-Amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3β, and PTEN
  Neurochemistry International, 2007
• Low serum VEGF levels are associated with Alzheimer's disease
  Acta Neurologica Scandinavica, 2006
• Neurovascular mechanisms of Alzheimer's neurodegeneration
  Trends in Neurosciences, 2005
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
  Nature Neuroscience, 2004
• RAGE (Yin) Versus LRP (Yang) Balance Regulates Alzheimer Amyloid β-Peptide Clearance Through Transport Across the Blood–Brain Barrier
  Stroke, 2004
• The biology of VEGF and its receptors
  Nature Medicine, 2003
• Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study
  Journal of Neurosurgery, 2003
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
  Science, 2002
• Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia
  Neurobiology of Aging, 2002